Sato, Kota http://orcid.org/0000-0001-9239-6003
Okazuka, Kiyoshi
Ishida, Tadao
Sakamoto, Jun
Kaneko, Shigeto
Nashimoto, Junichiro
Uto, Yui
Ogura, Mizuki
Yoshiki, Yumiko
Abe, Yu
Maeda, Aki
Hamazaki, Hiroyuki
Tsukada, Nobuhiro
Hiragohri, Yuji
Suzuki, Kenshi
Article History
Received: 10 February 2021
Accepted: 29 July 2021
First Online: 25 August 2021
Declarations
:
: This study was approved by the Ethics Committee of the Japanese Red Cross Medical Center.
: Written informed consent was obtained from all patients, in accordance with the Declaration of Helsinki.
: K. Suzuki received personal fees from Celgene, Takeda, Ono Pharmaceuticals, Astellas, Novartis, Sanofi, Bristol Myers Squibb, Janssen, and AbbVie. T. Ishida received personal fees from Janssen, Celgene, Ono Pharmaceuticals, and Takeda. N. Tsukada received personal fees from Takeda. J. Sakamoto, S. Kaneko, A. Maeda, H. Hamazaki, and Y. Hiragohri are employees of BML, Inc. The other authors declare no conflict of interest.